Biochemical and renal-metabolic profiles distinguishing primary aldosteronism from essential hypertension: a systematic review and meta-analysis with implications for endocrine hypertension screening

Front Endocrinol (Lausanne). 2026 Sep 15;17:1916237. doi: 10.3389/fendo.2026.1916237. eCollection 2026.ABSTRACTINTRODUCTION: To characterize electrolyte and renal-metabolic profiles in primary aldosteronism (PA) compared with essential hypertension (EH), and to examine differences between unilateral

X Xuan Zhao

GA Eases Atherosclerosis by Regulating Circadian Rhythm

Pharmazie. 2026 Sep 18;81(9):55101. doi: 10.31083/Pharmazie55101.ABSTRACTBACKGROUND: Atherosclerosis (AS) serves as a fundamental high-risk factor associated with the development of cardiovascular diseases. There is an urgent need to investigate efficacious therapeutic strategies and molecular targe

C Chengxin Hao

Next Generation Sequencing in the Diagnosis of Multiple Myeloma

Front Biosci (Schol Ed). 2026 Sep 4;18(3):44690. doi: 10.31083/FBS44690.ABSTRACTMultiple myeloma (MM) is a biologically and clinically heterogeneous plasma cell malignancy characterized by clonal expansion in the bone marrow and a highly variable clinical course. Despite major therapeutic advances,

I Ikram El Fazazi

Association of Short-Course Methylprednisolone Therapy With Early Composite Imaging Abnormalities in Patients With Early Neurological Deterioration After Endovascular Thrombectomy for Acute Ischemic Stroke

Rev Neurol. 2026 Sep 22;81(9):54438. doi: 10.31083/RN54438.ABSTRACTBACKGROUND: Early neurological deterioration (END) after endovascular thrombectomy (EVT) may be accompanied by heterogeneous postprocedural imaging abnormalities. We investigated the association between short-course methylprednisolon

C Changsi Ai